.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Federal Trade Commission
Cipla
Medtronic
Accenture
Johnson and Johnson
Harvard Business School
Teva
Farmers Insurance
Julphar

Generated: September 19, 2017

DrugPatentWatch Database Preview

Cerivastatin sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for cerivastatin sodium and what is the scope of cerivastatin sodium patent protection?

Cerivastatin sodium
is the generic ingredient in one branded drug marketed by Bayer Pharms and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: cerivastatin sodium

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list17
Clinical Trials: see list2,388
Patent Applications: see list3,932
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cerivastatin sodium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-002Jun 26, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-006Jul 24, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-001Jun 26, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-004Jun 26, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-003Jun 26, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-005May 24, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cerivastatin sodium

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Chinese Patent Office
Covington
Healthtrust
Daiichi Sankyo
Mallinckrodt
Harvard Business School
Cerilliant
QuintilesIMS
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot